Previous 10 | Next 10 |
2023-09-22 12:52:13 ET For further details see: CETX, MYO and MORF among mid-day movers
2023-09-22 09:59:56 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecuti...
Volition Hosts Key Opinion Leader Roundtable on Sepsis Management PR Newswire HENDERSON, Nev. , Sept. 13, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is hosting a Key Opinion Leader ("KOL"...
2023-08-15 12:27:14 ET VolitionRx Limited (VNRX) Q2 2023 Results Conference Call August 15, 2023 08:30 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - Founder, CEO, President and Director Terig Hughes - ...
VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Tuesday, August 15 , at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , Aug...
2023-08-14 10:17:31 ET Major earnings expected before the bell on Tuesday include: Cardinal Health ( CAH ) The Home Depot ( HD ) Jumia Technologies ( JMIA ) Seadrill ( SDRL ) Sea ( SE ) For further details see: Notable earnings before Tues...
VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Tuesday, August 15 at 8:30 a.m. Eastern Time HENDERSON, Nev , Aug. 9, 2023 /PRNewswire/ -- VolitionRx Limite...
VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters PR Newswire HENDERSON, Nev. , June 23, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that the un...
VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock PR Newswire HENDERSON, Nev. , June 5, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announc...
VolitionRx Limited Announces Pricing of $16.5 Million Underwritten Public Offering of Common Stock PR Newswire HENDERSON, Nev. , June 1, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics comp...
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) , a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures w...
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing PR Newswire HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaV...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...